Can intermittent fasting protect kidney function in diabetics?

How does intermittent fasting protect kidneys in diabetes?

Intermittent fasting appears to shield the kidneys through several interconnected mechanisms, primarily by lowering blood sugar, reducing inflammation, and dampening overactive metabolic pathways that damage kidney tissue. The clearest evidence comes from a 2025 study on diabetic mice, where a modified alternate-day fasting regimen (MADF) not only reduced hyperglycemia (high blood sugar) but also slowed the pathological progression of diabetic kidney disease (DKD) [4]. By analyzing the kidney tissue at the protein and metabolite level, the researchers found that MADF decreased levels of a protein called cathepsin S (CTSS), which is linked to inflammation and kidney damage, and increased protective metabolites like prostaglandin A1 [4]. This suggests IF directly alters the molecular environment in the kidneys.

A separate 2025 rat study specifically examined the polyol pathway — a metabolic route that becomes overactive under high blood sugar and contributes to kidney damage. The study found that combining IF with exercise and the diabetes drug glibenclamide provided synergistic protection against diabetic nephropathy by reducing activity in this pathway, boosting antioxidant defenses, and suppressing inflammation and fibrosis (scarring) [2]. The IF alone group also showed benefits, but the triple combination was most effective [2]. Together, these animal studies point to a consistent story: IF helps by tackling the root metabolic drivers of kidney injury in diabetes.

A 2026 study on diabetic rats compared different IF schedules and found that the 5:2 diet (fasting two days per week) produced the greatest improvements in blood sugar and cholesterol, though it also caused mild increases in creatinine, a marker of kidney stress [3]. This highlights that the type and intensity of fasting matter, and that careful monitoring is needed to avoid overstressing the kidneys.

What does the human evidence show?

Direct human evidence on IF and kidney function in diabetics is still sparse, but a compelling 2026 case report offers a real-world example. A 78-year-old man with a 40-year history of type 2 diabetes and 31 years of insulin dependence adopted a comprehensive lifestyle program that included intermittent fasting, a whole-food plant-based diet, yoga, and stress management [1]. Within one month, he was able to stop insulin entirely. After 10 months, his weight dropped from 71.9 kg to 62.5 kg, his HbA1c (a measure of average blood sugar over 2-3 months) improved from 7.0% to 6.6%, and critically, his kidney function remained stable throughout the 77-month follow-up [1]. While this is only a single case, it demonstrates that IF, as part of a broader lifestyle intervention, can be safely implemented even in elderly, long-standing diabetics without harming kidney function.

The animal studies provide the mechanistic backing for these human observations. The 2025 mouse study [4] and the 2025 rat study [2] both show that IF reduces markers of kidney fibrosis and inflammation, which are the underlying processes that lead to chronic kidney disease in diabetes. A 2025 study on mice with acute kidney injury (AKI) also found that a 5:2 IF regimen significantly reduced the progression from AKI to chronic kidney disease by lowering fibrosis, inflammation, and oxidative stress [5]. Although this study was not in diabetic animals, it reinforces the idea that IF has broad kidney-protective properties.

What are the cautions and practical considerations?

While the evidence is promising, it is not yet strong enough to recommend intermittent fasting as a standalone treatment for protecting kidney function in all diabetics. The most important caution comes from the 2026 rat study, which found that while the 5:2 diet improved blood sugar and cholesterol, it also led to elevated creatinine levels and mild histological changes in the kidneys, suggesting some degree of renal stress [3]. The authors advised that dietary fat modification and cautious fasting durations are needed to protect organ integrity [3]. This means that IF is not risk-free, especially for people with existing kidney impairment.

Another key point is that the strongest protective effects in the animal studies came from combining IF with other interventions — exercise and medication in the 2025 rat study [2], or a comprehensive lifestyle program in the 2026 human case [1]. This suggests IF is best viewed as part of a multi-pronged strategy, not a magic bullet. Additionally, all the animal studies used specific IF protocols (alternate-day fasting, 5:2 diet, or time-restricted feeding), and the effects varied by protocol [3]. A person with diabetes should not start any fasting regimen without medical supervision, as it can affect blood sugar levels and medication requirements, potentially leading to dangerous hypoglycemia (low blood sugar).

Finally, the human evidence is limited to a single case report [1]. Larger, randomized controlled trials in humans are urgently needed to confirm these findings and establish safe, effective protocols. Until then, anyone considering IF for kidney protection should work closely with their healthcare team to monitor kidney function, blood sugar, and overall health.

About These Sources

This answer is built on 5 peer-reviewed studies — published from 2025 to 2026, 5 from 2024 or later, 2 in Q1 journals — selected as the most relevant from 5 studies that passed quality screening, drawn from 46 papers retrieved from a database of over 500 million.

Sources used in this answer

Related research questions